secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRYO CELL INTERNATIONAL INC (CCEL)
CIK:        0000862692
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001193125-26-214569
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NYSE American accepts Cryo-Cell compliance plan; trading continues through Sep 2027
--------------------------------------------------------------------------------

- Received notice of non-compliance on Mar 12, 2026 for stockholders' deficit and net losses in two of three fiscal years ending Nov 30, 2025.
- Compliance plan accepted May 6, 2026; plan period extends to September 9, 2027 to regain listing standards.
- Common stock remains listed and traded on NYSE American during plan period, subject to periodic review.
- Failure to regain compliance or make progress by deadline could result in delisting proceedings.
- Company reported stockholders' deficit as of Nov 30, 2025 and net losses in FY2023, FY2024, FY2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/862692/000119312526214569/0001193125-26-214569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/862692/000119312526214569/ccel-20260506.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-214569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer